Recent studies have revealed that arginine vasopressin (AVP) has at least two types of receptors in the kidney: Vla receptor and V2 receptor. In this study, microlocalization of mRNA coding for Vla and V2 receptors was carried out in the rat kidney using a reverse transcription and polymerase chain reaction. Large signals for Vla receptor PCR product were detected in the glomerulus, initial cortical collecting duct, cortical collecting duct, outer medullary collecting duct, inner medullary collecting duct, and arcuate artery. Small but detectable signals were found in proximal convoluted and straight tubules, inner medullary thin limbs, and medullary thick ascending limbs. Large signals for V2 receptor mRNA were detected in the cortical collecting duct, outer medullary collecting duct, and inner medullary collecting duct. Small signals for V2 receptor were found in the inner medullary thick limbs, medullary thick ascending limbs, and initial cortical collecting duct. Next, we investigated Vla and V2 receptor mRNA regulation in the dehydrated state. During a 72-h water restriction state, the plasma AVP level increased and V2 receptor mRNA decreased in collecting ducts. In contrast, Vla receptor mRNA did not change significantly. Thus, the two AVP receptor subtypes are distributed differently along the nephron, and these mRNAs are regulated differently in the dehydrated state. (J. Clin. Invest.
Introduction
The antidiuretic hormone arginine vasopressin (AVP)' is known to influence the glomerular function and to increase the water permeability of the collecting duct and it has also been shown to act on other nephron segments, in the mammalian kidney ( 1, 2) . AVP receptors are G protein-coupled and have 1 . Abbreviations used in this paper: AVP, arginine vasopressin; iCCD, initial cortical collecting duct; IMCD, inner medullary collecting duct; IMTL, inner medullary thin limb; MTAL, medullary thick ascending limb; OMCD, outer medullary collecting duct; PCT, proximal converted tubule; PST, proximal straight tubule; RT-PCR, reverse transcription PCR.
been divided into at least three types: Vla (vascular/hepatic) and Vlb (anterior pituitary) receptors, which act through phosphatidylinositol hydrolysis to mobilize intracellular Ca2"; and V2 (kidney) receptor, which is coupled to adenylate cyclase (3) . Recently, Vl a and V2 receptor cDNAs were cloned (4) (5) (6) . These cDNAs encode proteins with seven putative transmembrane domains and a similar structure to rhodopsin and other G protein-coupled receptors (4) (5) (6) .
The distribution of Vla and V2 receptors in the kidney has been investigated by binding studies (7-1 1 ) and many physiological studies (12) (13) (14) (15) (16) (17) . The presence of V2 receptor in the collecting duct is well established (9, 11, 18) . However, in MTAL and glomerulus, the presence of V2 receptor is controversial. It is also not well clarified whether V2 receptor is expressed or not in IMTL and the renal vascular system.
Recently, some reports revealed that Vla receptor is expressed in the glomerular mesangial cell ( 19) , CCD (1 1, 16), OMCD ( 11) , and IMCD ( 11). Ando et al. reported that AVP action from the apical side may be mediated via Vla receptor in rabbit CCD (20) . On the other hand, binding studies could not detect Vla binding sites in glomerulus (7) (8) (9) (10) . Thus, the presence ofVla receptor in the kidney is still controversial. To understand clearly the physiological function of AVP in the kidney, it seems very important to know the precise localization of both types of receptor expressions along the nephron segments and in the renal vascular system. AVP plays critical roles in maintaining body homeostasis in water restricted conditions. In the dehydrated state, the plasma AVP level increases and water and solute are reabsorbed in the collecting ducts (21, 22) . Downregulation or desensitization of AVP receptor have been reported when the plasma AVP level increases (23, 24) . The mechanism of this phenomenon is not well known. It has not been well investigated which type of receptor is regulated by the plasma AVP level. Therefore, we investigated the regulations of mRNA expressions of VI a and V2 receptors in water restricted rats.
Recently, Moriyama et al. (25) and Terada et al. (26) introduced a new method for measurement of relative levels of specific mRNA in single microdissected renal tubules, using the PCR coupled to reverse transcription (RT-PCR). Using this technique, relative quantitation of mRNA coding for peptide hormone receptor was performed from only 2-mm lengths of renal tubules (26) .
In the present study, we used the RT-PCR technique for the precise localization and regulation of V 1 a and V2 receptor mRNAs in microdissected renal tubules, glomeruli, and arcuate arteries.
capitation. The aorta was cannulated with polyethylene tubing below the left kidney, and the left kidney was perfused in vivo. The kidney was perfused initially with 10 ml of ice-cold dissection solution (solution 1 ) and then with 10 ml of the same solution containing 1 mg/ml collagenase (collagenase solution) (type I, 300 U/mg; Sigma Chemical Co., St. Louis, MO) and 1 mg/ml bovine serum albumin (Sigma Chemical Co.). The dissection solution (solution 1) contained the following(in mM): 135 NaCl, 1 Na2SO4, 1.2 MgSO4, 5 KCl, 2 CaCl2,5.5 glucose, and 5 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Hepes) (pH 7.4). The left kidney was removed and a coronal section was made that contained the entire corticopapillary axis. This section was cut into three pieces: cortex, outer medulla, and inner medulla. These pieces were transferred into individual tubes containing 1 ml of the same collagenase solution that was used to perfuse the kidney. The tubes were incubated for 30 min (cortex and outer medulla) or 40 min (inner medulla) at 370C in a shaking water bath. The solutions were bubbled with 100% oxygen during these incubations. Then tissues were transferred to the dissection solution containing 10 mM vanadyl ribonucleotide complex (Life Technologies, Inc., Gaithersburg, MD), a potent RNase inhibitor, and they were placed on ice until microdissection.
After previously described techniques (26) (27) . The protein level of Glm was determined using protein assay reagent (Bio-Rad Laboratories, Richmond, CA).
Microdissected tubules, glomeruli, arcuate arteries were washed free of contaminating debris and vanadyl ribonucleotide complex in separate wash dishes. These structures were transferred into appropriate RT-PCR reaction tubes, which contained 10 AI of ice-cold dissection solution containing > 1 U/,ul ofhuman placental RNase inhibitor (Boehringer-Mannheim GmbH., Mannheim, Germany) and 5 mM dithiothreitol (Sigma Chemical Co.).
Reverse transcription. RT was performed using a cDNA synthesis kit (Boehringer-Mannheim GmbH.). The RNase-inhibitor solution was removed, and 9 Ml of 2% Triton X-100, containing > 1 U/Ml of RNase-inhibitor, 5 mM DTT, and 3 U RNase-free DNase (Pharmacia Fine Chemicals, Piscataway, NJ), was added to permeabilize the cells, followed by incubation at 37°C for 30 min to digest the genomic DNA.
The samples were heated to 90°C for 5 min to inactivate the DNase. RT components were added to the reaction tubes as described previously (26): 4 ,l ofbuffer I, 1 Ml ofRNase inhibitor, 2 Ml ofdeoxynucleotide mixture, 2 Al of random primer, and 2 Ml of avian myeloblastoma virus reverse transcriptase. Reaction tubes were incubated at 42°C for 60 min in the Programmed Tempcontrol System (Astec, Tokyo, Japan). At the end ofthe incubation period, the reaction was stopped by heating at 90°C for 5 min. This heat treatment also denatures RNAcDNA hybrids and inactivates the reverse transcriptase. Then the reaction tubes were placed on ice until the addition of PCR reagents.
Polymerase chain reaction. PCR was performed using the GeneAmp DNA Amplification Reagent Kit (Perkin-Elmer Cetus, Norwalk, CT), with rat Vla and V2 receptor specific primers prepared on a DNA synthesizer (Applied Biosystems Inc., Tokyo, Japan). We designed specific primers [20] [21] [22] [23] [24] [25] nucleotides in length with 50-60% GC composition. The resultant high calculated melting temperature (> 75°C) allows a stringent annealing temperature in the PCR cycle. V 1 a receptor primer 1 (antisense) was defined by bases 579-598, and primer 2 (sense) encompassed bases 1-21 (4). The sequence of Vla primer 1 was 5'-TAGTGCCATTGTTCACCTCG-3', primer 2 was 5'-ATGAG-TTTCCCGCGAGGCTCC-3'. The predominant cDNA amplification product was predicted to be 598 bp in length (the distance between primers plus primer length). A third oligonucleotide was synthesized to serve as an amplification product-specific probe. This oligonucleotide (sense) included bases 444-463 of the cDNA, positioned between primer 1 and primer 2. The sequence of this oligonucleotide probe was 5'-TACATCGCCGTGTGCCACCC-3'.
V2 receptor primer 1 (antisense) was defined by bases 581-600, and primer 2 (sense) encompassed bases -24 to -3 (6). The sequence of V2 receptor primer 1 was 5'-CCATGGTTCTGCAAATCGGG-3', primer 2 was 5'-TAGGTCATCATCAACCACCCCA-3'. The predominant cDNA amplification product was predicted to be 625 bp in length. A third oligonucleotide was synthesized to serve as an amplification product-specific probe. This oligonucleotide (sense) included bases 307-326 of the cDNA, positioned between primer 1 and primer 2. The sequence of this oligonucleotide probe was 5'-ACCGCTTC-CATGGCCCTGAT-3'.
RT and PCR of GAPDH served as a positive control. The primers were defined by the following cDNA base sequences (28): primer 1 (antisense), bases 794-813, sequence, 5'-AGATCCACAACGGATA-CATT-3'; primer 2 (sense), bases 506-525, sequence, 5'-TCCCTC-AAGATTGTCAGCAA-3'. The cDNA amplification product was predicted to be 309 bp in length. A third oligonucleotide was synthesized to serve as an amplification product-specific probe. This oligonucleotide (sense) included bases 307-326 ofthe cDNA, positioned between primer 1 and primer 2. The sequence ofthis oligonucleotide probe was 5'-ACCGCTTCCATGGCCCTGAT-3'. When we used GAPDH as an internal control primer, after reverse transcription, we divided 20 Ml samples into 15 Ml for Vla or V2 receptor and 5 Ml for GAPDH. The volume was adjusted to 20 ,l with sterile water. Then we ran parallel PCR reactions with each set of primers.
To carry out the PCR, 80 Ml ofa PCR master mix was added to each tube directly. 50 pmol ofeach ofprimers 1 and 2 was used per reaction for both Vla and V2 receptor. Deoxynucleotides were added to a final concentration of 0.20 mM each. Reaction buffer (lOX) was diluted ('hio) to have a final composition of: 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2, and 0.001% (wt/vol) gelatin, 2.5 U ofTaq DNA polymerase.
100 Ml of mineral oil was overlayed to prevent evaporation during the high temperature incubations. The tubes were placed in the Programmed Tempcontrol System programmed as follows. First, incubation at 94°C for 3 min (initial melt). Then, 30 cycles of the following sequential steps: 94°C for 1 min (melt), 60°C for 1 min (anneal), and 72°C for 3 min (extend). And last, incubation at 72°C for 7 min (final extension). Then samples were kept at 4°C until the time of analysis.
PCR product analysis. 90 Ml of the total reaction volume was ethanol precipitated (29) . The PCR products were size-fractionated by 2% agarose gel electrophoresis. After electrophoresis and ethidium bromide staining, DNA bands were visualized with an ultraviolet transilluminator (Funakoshi, Tokyo, Japan).
For Southern blot analysis, gels were blotted onto a nitrocellulose filter (Funakoshi) essentially as described by Maniatis et al. (29) . The synthetic oligonucleotide probes were end-labeled with 32p as described previously (26) . Prehybridization/hybridization washes were also the same as previously described (26) .
To confirm that the PCR products were really Vla and V2 receptor cDNAs, the PCR products were sequenced. PCR products from glomeruli were separated by gel electrophoresis. PCR products ofVla and V2 receptors were subcloned into pGEM-3Zf(-) vector (Promega Biotec, Madison, WI) as described by Finney (30). We cut pGEM3Zf( -) vector at SamI site, and thymine was attached at 3' end using Taq DNA polymerase (Perkin-Elmer Cetus), because Taq DNA polymerase has terminal transferase activity. The PCR product has adenine in its 3' end. We ligated PCR products and pGEM-3Zf(-), then sequenced using the dideoxynucleotide chain termination reaction of Sanger et al. ( 31 ) .
Relative-quantitation of mRNA levels from autoradiographs. The relative amount of PCR products was determined by densitometer scanning of autoradiographs using a laser densitometer (Hoefer Scientific Instruments, Inc., San Francisco, CA). For relative quantitation, we used the densitometry value from the 2 mm of same nephron segments, and adjusted the densitometry values with the GAPDH band intensity.
To test the relationship between the quantity of starting material and that of amplification product as reflected by densitometry values, we compared amplification products from several lengths of renal tubules. We compared amplification products from several lengths of OMCD (0.2-2.0 mm, n = 12) for Vla receptor and IMCD (0.2-2.0 mm, n = 12) for V2 receptor. Linear regression analysis showed high correlation between densitometry values and the length of each tubule for Vla receptor (r = 0.95) and V2 receptor (r = 0.95) (data not shown).
Water restriction experiments. The water restricted experiments were performed using male Sprague-Dawley rats weighing 75-100 g (n = 6 per group). The normal rat group was given a standard diet and allowed free access to tap water. The dehydration experiment group was deprived ofwater for 6, 12, 24, 48, and 72 h before death. The rats were anesthetized intraperitoneally with pentobarbital sodium (50 mg/kg) and the blood samples were taken from the heart. Plasma AVP was measured by radioimmunoassay with specific AVP antibody (AVP-RIA kits, Mitsubishiyuka, Tokyo, Japan) as previously described (32). Briefly, the purification process is as follows: SepPak C 18 cartridges (Waters Associates, Milford, MA) were prewetted with 10 ml methanol. A 1-ml plasma sample is acidified with 0.1 N HCl and applied to the column dropwise. The cartridge is rinsed with 10 ml 4% acetic aci,-andl then AVP k eintedl with 1 Statistics. The results were given as mean±SEM. The differences were tested using analysis of variance. P < 0.05 was considered signifi- (Fig. 1) . With reverse transcription, we detected ,carried out with a clear single band, which was the predicted size of 598 bp for aosmolality was V la receptor from OMCD (Fig. 1, A and B) , and we also ic., Logan, UT).
detected a clear single band, which was the predicted size of625 adjusted by the bp for V2 receptor from IMCD (Fig. 1, C and D) . When the PCR procedure was carried out in the absence of reverse transcriptase, the 598-bp band and the 625-bp band were not seen, and there was no other recognizable band. This indicated that the 598-bp and the 625-bp bands originated from mRNA, not from genomic DNA, which was presumably digested by DNase treatment. The Southern blots of the gels demonstrated that V la specific probe binds to the 598-bp product, and V2 specific 625bp probe binds to the 625-bp product, confirming their identity.
Specificity of VIa and V2 probes to PCR products (Fig. 2) . We performed PCR amplification in the presence of both V a and V2 receptor primers from OMCD. As shown in Fig. 2 A, the 598-bp band and 625-bp band are clearly distinguished in 2% agarose gel. V I a probe hybridized to the 598-bp band specifically and did not hybridize to 625-bp band (Fig. 2 B) . V2 probe hybridized to 625-bp band specifically and did not hybridize to 598-bp band (Fig. 2 C) .
Distribution of Vla and V2 receptors mRNAs in microdissected structures (Fig. 3) . Each reaction was performed using either 2-mm oftubule length, five glomeruli, or 2-mm length of NAs amplificaarcuate artery. A single band of predicted size (598 bp) was ned from 2 mm consistently found from Glm, iCCD, CCD, OMCD, IMCD, with and withand arcuate artery (Fig. 3 A) . A faint but detectable band was ined agarose gels found from PCT, PST, IMTL, and MTAL (Fig. 3 B) . The nucleotide that Southern blots of the gels demonstrated specific binding of the idium bromideoligonucleotide probe to the 598-bp product (Fig. 3 B) . We rams of correconfirmed that the PCR product had an identical sequence to h a 32P-labeled V la receptor cDNA by sequencing the subcloned PCR prod-)r primers.
uct. The largest signal for VIa receptor was detected in Glm. (Fig. 3 E) . We obtained similar results for V la and V2 receptors from five experiments of five rats.
VIa and V2 receptor mRNA regulation by dehydration in rat glomeruli and collecting ducts (Fig. 4) . The state of dehy-I'598 bp dration ofthe rats was evaluated by comparing plasma osmolali|iJU LJP ity and plasma AVP concentration among the two groups.
Plasma osmolality was significantly elevated in the 72-h water restricted animals (306±2.5 mosmol/kg) compared with control values (290±1.1 mosmol/kg) (P < 0.05). Plasma AVP levels also were significantly increased, at 23.4-fold, in animals in the 72-h water restricted group (77.5±17.4 pg/ml) compared with control values (3.3±0.9 pg/ml). Vla receptor expressions did not significantly change between the two groups in glomeruli and collecting ducts (Fig. 4, A and B) . On the '625 b other hand, V2 receptor mRNA expressions in collecting ducts U PJ 'J decreased in water restricted rats (Fig. 4, D (Fig. 3 C) . This band was the predicted size (625 bp). The Southern blots of the gels demonstrated specific binding ofthe oligonucleotide probe to the 625-bp product (Fig. 3 D) . We confirmed that PCR product had an identical sequence to V2 receptor cDNA by sequencing the subcloned PCR product. Among renal tubule segments, the largest signal was consis- Time course of V2 and Vla receptor expression in IMCD during dehydration (Fig. 5) . Plasma osmolality was significantly elevated from 24-h water restriction (299±2.5 mosmol/ kg) compared with control values (290±1.1 mosmol/kg) (n = 5, mean±SEM, P < 0.05). Plasma AVP levels were also increased from control values (3.3±0.9 pg/ml) as follows: (10.7±2.5) at 6 h, (37.5±5.2) at 12 h, (44.0±3.8) at 24 h, (52.3±8.5) at 36 h, (58.5± 10.3) at 48 h, and (88.5± 19.2) at 72 h in water restricted rats. Vla receptor expressions did not significantly change during experiments in IMCD (Fig. 5, A  and B) . On the other hand, V2 receptor mRNA expressions in IMCD decreased from 12-h water restriction and gradually decreased to 72 h in water restricted rats (Fig. 5, D and E) . The PCR products for V2 receptor decreased to 75.8±8.8% in 12 h (n = 5, vs control group), 66.3±9.4% in 24 h, 60.7±9.2% in 36 h, 53.8±7.9% in 48 h, and 43.8±11.2% in 72 h in water restriction rat group. The values were corrected by the band intensity of GAPDH band intensity of the same sample.
Discussion
AVP is reported to reduce the glomerular ultrafiltration permeability coefficient (Kf) and decrease the glomerular filtration rate (33) . It has been shown that AVP stimulates contraction ofcultured glomerular mesangial cells via a rise in intracellular Ca2" (34) . This effect is considered to be through the Vla receptor (19, 34) . It is not known, however, if the native glomerulus expresses the Vi a receptor. In fact, no autoradiographic studies have demonstrated V 1 a specific glomerular binding on native renal tissue (7) (8) (9) (10) . The presence of the V2 receptor in glomerulus is not well established either. Imbert et al. (35) showed that 10-10 M AVP produces a small but significant stimulatory effect on the adenylate cyclase activity in isolated rabbit glomeruli, but others did not (36, 37) . Our data show that VI a, and not V2 receptor mRNA is expressed in rat glomerulus. Therefore, the action of AVP to influence glomerular function may be mediated by the VIa receptor.
Only a few studies have been carried out to investigate AVP effect on proximal tubules. Binding studies (7) (8) (9) (10) and microdissection studies (12, 14) had no positive results for AVP effect in proximal tubule. We could not detect V2 receptor mRNA from PCT or PST. The VIa receptor mRNA levels in PCT and PST are very small compared with glomerulus or collecting ducts, and the physiological significance of this expression is unclear.
Imbert et al. (14) reported that there is a small but statistically significant cAMP increase induced by AVP in thin limbs. We detected a very low level of Vla and V2 mRNAs from IMTL, although it was impossible to discern whether the expression was in ascending or descending limbs. Physiological function of these receptor in thin limbs is unknown.
There is general agreement about the V2 receptors play an important regulatory role in the MTAL, but the possible role of VIa receptors is uncertain. Autoradiographic studies using 3H-AVP and VI a and V2 antagonist show binding sites are present in outer and inner medulla (7) (8) (9) (10) . AVP has been reported to stimulate adenylate cyclase activities of MTAL of rabbit, rat, and mouse kidneys, but not ofhuman and dog kidneys (12, 14, 38) . In vitro microperfusion studies showed that AVP stimulates NaCl transport in rabbit, rat, and mouse kidneys (39, 40) , possibly through the V2 receptor. Recently, Ammar et al. (11) reported, using V la and V2 specific ligands, that not only V2 but also VI a receptor is present in MTAL. Our results show that both V2 and V I a receptor mRNAs are indeed expressed in MTAL. Nitschke et al. reported that the VIa receptor mediated intracellular Ca 2+ increment in cortical thick ascending limbs (17) . Prostaglandin E2, which may be synthesized via VIa receptor (41), inhibits AVP-dependent stimulation of NaCl transport in mouse MTAL (42) . Thus, VIa receptor may play some role in the self-inhibition of AVP in the MTAL.
Collecting tubules are the major target for physiological action of AVP in the kidney (43) . AVP at the physiological concentration 10"1 M can increase the hydro-osmotic water permeability and adenylate cyclase activity in the collecting tubules (18) . Recently, AVP was reported to increase intracellular Ca2+ in CCD (16), IMCD (44) , and cultured IMCD cells (45) . Initial observation in CCD indicated that AVP evokes a transient rise in intracellular Ca2 , probably through V I a receptor (16). However more recent studies using IMCD cells showed that both AVP and l-desamino-8-D-arginine vasopressin, on an equimolar basis, evoke a rise in intracellular Ca2 , suggesting the mediation of V2 receptor (45) or possibly heretofore unknown receptor type (46 Protein synthesis is determined by both mRNA level and by the efficiency of mRNA transcription. The rate of VIa and V2 receptor mRNA translation has not been evaluated here, nor have the levels of protein expression been investigated. Therefore, it seems very difficult to speculate about the relationship between the amount of mRNA level and the number of receptors present in cell surface. The RT-PCR technique is so sensitive that some proteins may not be detectable in the cell despite the presence of mRNA according to RT-PCR (51) . Thus the presence of VI a and V2 receptor mRNA does not imply necessarily the existence of its functional protein product in the nephron segments. In particular, it must be careful with regard to the presence of functional receptor protein, when we detect very small levels PCR product such as VI a receptor mRNA in PST and PCT.
In summary, our data show that mRNA coding for the two AVP receptor subtypes are distributed differently along the nephron and renal vascular system, and that these mRNAs are regulated differently in response to the dehydrated state. These results are consistent with the view that the two type receptors may play different roles in modulating renal functions.
